REQUEST A DEMO
Total
USD $0.00
Search more companies

Acme Therapeutics (I) Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Acme Therapeutics (I) Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Acme Therapeutics (i) Private Limited is an unlisted company, incorporated on 14/03/2001. It has its registered office in the State of Haryana, India. Company's corporate identification number (CIN) is U24232HR2001PTC093261 and registration number is 093261. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Flat No 1601, Tower 7A Suncity Parikrama, Sector 20
Panchkula; Haryana; Postal Code: 134109

Contact Details: Purchase the Acme Therapeutics (I) Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Acme Therapeutics (I) Private Limited report to view the information.
Outstanding Shares:
Purchase the Acme Therapeutics (I) Private Limited report to view the information.
Registered Capital:
Purchase the Acme Therapeutics (I) Private Limited report to view the information.
Incorporation Date:
March 14, 2001
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Acme Therapeutics (I) Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
3.98%
Total operating revenue
4.01%
Operating profit (EBIT)
1.45%
EBITDA
-1.27%
Net Profit (Loss) for the Period
-0.14%
Total assets
2.26%
Total equity
13.16%
Operating Profit Margin (ROS)
-0.17%
Net Profit Margin
-0.2%
Return on Equity (ROE)
-1.54%
Debt to Equity Ratio
-2.69%
Quick Ratio
0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?